SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans
2021; Cell Press; Volume: 185; Issue: 4 Linguagem: Inglês
10.1016/j.cell.2021.12.026
ISSN1097-4172
AutoresPhilip A. Mudd, Anastasia A. Minervina, Mikhail V. Pogorelyy, Jackson S. Turner, Wooseob Kim, Elizaveta Kalaidina, Jan Petersen, Aaron J. Schmitz, Tingting Lei, Alem Haile, Allison M. Kirk, Robert C. Mettelman, Jeremy Chase Crawford, Thi H. O. Nguyen, Louise C. Rowntree, Elisa Rosati, Katherine A. Richards, Andrea J. Sant, Michael K. Klebert, Teresa Suessen, William D. Middleton, Joshua Wolf, Sharlene A. Teefey, Jane A. O’Halloran, Rachel M. Presti, Katherine Kedzierska, Jamie Rossjohn, Paul G. Thomas, Ali H. Ellebedy, Jeremie H. Estepp, Stacey Schultz‐Cherry, Maureen A. McGargill, Aditya H. Gaur, James E. Hoffman, Motomi Mori, Li Tang, Elaine Tuomanen, Richard J. Webby, Randall T. Hayden, Hana Hakim, Diego R. Hijano, Kim Allison, E. Kaitlynn Allen, Resha Bajracharya, Walid H. Awad, Lee-Ann Van de Velde, Brandi L. Clark, Taylor L. Wilson, Aisha Souquette, Ashley Castellaw, Ronald H. Dallas, Ashleigh Gowen, Thomas Fabrizio, Chun-Yang Lin, David C. Brice, Sean Cherry, Ericka Kirkpatrick Roubidoux, Valerie Cortez, Pamela Freiden, Nicholas Wohlgemuth, Kendall Whitt,
Tópico(s)Immunotherapy and Immune Responses
Referência(s)